[Paper-level Aggregated] PMCID: PMC4234187

Evidence Type(s): Functional

Summary: Mutation: C118S | Summary: The C118S mutation alters the molecular function of Ras by blocking activation, affecting the ability of eNOS to stimulate the MAPK pathway, and influencing signaling pathways related to oncogenic activity. It also alters tumor size and incidence of adenomas, as evidenced by reduced P-Akt levels and changes in P-Erk1/2 levels upon EGF treatment. Additionally, the presence of the KrasC118S allele suggests a change in molecular or biochemical function, although specific functional impacts are not detailed.

Evidence Type: Functional Mutation: S1177D | Summary: The S1177D mutation in eNOS alters the levels of phosphorylated Erk1/2, demonstrating a change in biochemical function.

Evidence Type: Functional Mutation: G13D | Summary: The G13D mutation, when combined with C118S, affects the molecular function of Kras, influencing signaling pathways related to oncogenic activity.

Gene→Variant (gene-first): NOS2(4843):C118S NOS3(4846):S1177D KRAS(3845):G13D

Genes: NOS2(4843) NOS3(4846) KRAS(3845)

Variants: C118S S1177D G13D

[Paper-level Aggregated] PMCID: PMC4234187

Evidence Type(s): Oncogenic

Summary: Mutation: C118S | Summary: The C118S mutation in the Kras gene is implicated in tumorigenesis, contributing to tumor development and progression. It is associated with a reduction in tumor burden and a shift towards smaller tumors in mice, and it is involved in the sensitivity of tumor initiation to Ras protein levels. The KrasC118S allele is also described as having a negative effect on lung tumorigenesis, suggesting it may suppress the tumorigenic activity of the oncogenic Kras allele. Additionally, it is investigated for its role in tumorigenesis, showing that it impedes urethane-induced lung tumor development.

Evidence Type: Oncogenic Mutation: G12D | Summary: The G12D mutation is associated with tumor development, promoting tumorigenesis as indicated by its presence in the KrasLSL-G12D/+ and KrasLSL-G12D/C118S mice models.

Evidence Type: Oncogenic Mutation: Q61R | Summary: The Q61R mutation in the native Kras allele is identified as oncogenic, contributing to tumor development in the analyzed lung tumors from Kras+/C118S mice.

Evidence Type: Oncogenic Mutation: Q61R/L | Summary: The Q61R/L mutations in Kras are characterized as oncogenic, contributing to tumor development and progression in the context of urethane-induced lung tumors.

Evidence Type: Oncogenic Mutation: G13D | Summary: The KrasG13D mutation is described as an oncogenic mutant, indicating its role in tumor progression.

Gene→Variant (gene-first): NOS2(4843):C118S KRAS(3845):G12D NRAS(4893):Q61R KRAS(3845):Q61R/L KRAS(3845):G13D

Genes: NOS2(4843) KRAS(3845) NRAS(4893)

Variants: C118S G12D Q61R Q61R/L G13D

[Paragraph-level] PMCID: PMC4234187 Section: ABSTRACT PassageIndex: 1

Evidence Type(s): Oncogenic, Functional

Summary: Evidence Type: Oncogenic | Mutation: C118S | Summary: The C118S mutation in the Kras gene is investigated for its role in tumorigenesis, showing that it impedes urethane-induced lung tumor development, indicating its contribution to cancer progression. Evidence Type: Functional | Mutation: C118S | Summary: The C118S mutation alters the molecular function of the Kras protein, as it affects the activation and subsequent tumorigenic potential in response to carcinogen exposure.

Gene→Variant (gene-first): 4843:C118 4843:C118S 4843:cysteine 118

Genes: 4843

Variants: C118 C118S cysteine 118

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 16

Evidence Type(s): Oncogenic, Functional

Summary: Evidence Type: Oncogenic | Mutation: C118S | Summary: The KrasC118S mutation is implicated in oncogenic behavior, particularly in the context of the KrasG13D background, suggesting its contribution to tumor development. Evidence Type: Oncogenic | Mutation: G13D | Summary: The KrasG13D mutation is described as an oncogenic mutant, indicating its role in tumor progression. Evidence Type: Functional | Mutation: C118S | Summary: The C118S mutation alters the signaling and transformation properties of Kras, as evidenced by changes in P-Erk1/2 levels upon EGF treatment. Evidence Type: Functional | Mutation: G13D | Summary: The G13D mutation, when combined with C118S, affects the molecular function of Kras, influencing signaling pathways related to oncogenic activity.

Gene→Variant (gene-first): 4843:C118 4843:C118S 3845:G13D 4893:Q61L

Genes: 4843 3845 4893

Variants: C118 C118S G13D Q61L

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 15

Evidence Type(s): Oncogenic

Summary: Evidence Type: Oncogenic | Mutation: C118S | Summary: The C118S mutation in the Kras allele is associated with oncogenic behavior, as it was tested in Kras+/C118S mice and analyzed for its role in tumor development. Evidence Type: Oncogenic | Mutation: Q61R | Summary: The Q61R mutation in the native Kras allele is identified as oncogenic, contributing to tumor development in the analyzed lung tumors from Kras+/C118S mice. Evidence Type: Oncogenic | Mutation: Q61R/L | Summary: The Q61R/L mutation is classified as oncogenic, as it was detected in the native Kras allele and is implicated in tumor progression in the studied samples.

Gene→Variant (gene-first): 4843:C118S 4893:Q61R 3845:Q61R/L

Genes: 4843 4893 3845

Variants: C118S Q61R Q61R/L

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 13

Evidence Type(s): Oncogenic

Summary: Evidence Type: Oncogenic | Mutation: C118S | Summary: The KrasC118S allele is described as having a negative effect on lung tumorigenesis, suggesting it may suppress the tumorigenic activity of the oncogenic Kras allele. Evidence Type: Oncogenic | Mutation: G12D | Summary: The KrasG12D allele is established to promote tumorigenesis, indicating its role as an oncogenic mutation in lung cancer development.

Gene→Variant (gene-first): 4843:C118S 3845:G12D

Genes: 4843 3845

Variants: C118S G12D

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 12

Evidence Type(s): Oncogenic

Summary: Evidence Type: Oncogenic | Mutation: G12D | Summary: The G12D mutation is associated with tumor development as indicated by its presence in the KrasLSL-G12D/+ and KrasLSL-G12D/C118S mice models. Evidence Type: Oncogenic | Mutation: C118S | Summary: The C118S mutation contributes to tumor development, as evidenced by its presence in the KrasLSL-G12D/C118S mouse model alongside the G12D mutation.

Gene→Variant (gene-first): 4843:C118S 3845:G12D

Genes: 4843 3845

Variants: C118S G12D

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 11

Evidence Type(s): Oncogenic, Functional

Summary: Evidence Type: Oncogenic | Mutation: C118S | Summary: The C118S mutation in Kras is associated with tumor progression and is implicated in the development of mixed solid/papillary adenomas, indicating its role in tumor development. Evidence Type: Functional | Mutation: C118S | Summary: The C118S mutation appears to alter the molecular function of Ras signaling, as evidenced by the reduced P-Akt levels in the Kras+/C118S cohort compared to other genotypes.

Gene→Variant (gene-first): 4843:C118S

Genes: 4843

Variants: C118S

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 10

Evidence Type(s): Oncogenic, Functional

Summary: Evidence Type: Oncogenic | Mutation: C118S | Summary: The KrasC118S allele is associated with a reduction in tumor burden and a shift towards smaller tumors in mice, indicating its role in tumor development and progression. Evidence Type: Functional | Mutation: C118S | Summary: The presence of the KrasC118S allele alters the tumor size and incidence of adenomas, suggesting a change in molecular or biochemical function related to carcinogenesis.

Gene→Variant (gene-first): 4843:C118S

Genes: 4843

Variants: C118S

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 9

Evidence Type(s): Oncogenic

Summary: Evidence Type: Oncogenic | Mutation: C118S | Summary: The KrasC118S mutation is implicated in tumor development as it is assessed in the context of lung tumors induced by the carcinogen urethane. Evidence Type: Oncogenic | Mutation: Q61R/L | Summary: The Q61R/L mutations in Kras are characterized as oncogenic, contributing to tumor development in the context of urethane-induced lung tumors.

Gene→Variant (gene-first): 4843:C118S 3845:Q61R/L

Genes: 4843 3845

Variants: C118S Q61R/L

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 7

Evidence Type(s): None

Summary: Not enough information in this passage.

Gene→Variant (gene-first): 4843:C118S

Genes: 4843

Variants: C118S

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 6

Evidence Type(s): Functional

Summary: Evidence Type: Functional | Mutation: C118S | Summary: The C118S mutation is mentioned in the context of KrasC118S/C118S mice appearing normal, suggesting that this variant may alter molecular or biochemical function, although the specific functional impact is not detailed.

Gene→Variant (gene-first): 4843:C118S

Genes: 4843

Variants: C118S

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 5

Evidence Type(s): Oncogenic, Functional

Summary: Evidence Type: Oncogenic | Mutation: C118S | Summary: The C118S mutation in the Kras gene is associated with tumorigenesis, as it is involved in the sensitivity of tumor initiation to Ras protein levels. Evidence Type: Functional | Mutation: C118S | Summary: The C118S mutation affects the ability of eNOS to stimulate the MAPK pathway, indicating a change in molecular function. Evidence Type: Functional | Mutation: S1177D | Summary: The S1177D mutation in eNOS alters the levels of phosphorylated Erk1/2, demonstrating a change in biochemical function.

Gene→Variant (gene-first): 4843:C118S 4843:G353>C 4846:S1177D

Genes: 4843 4846

Variants: C118S G353>C S1177D

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 3

Evidence Type(s): Functional, Oncogenic

Summary: Evidence Type: Functional | Mutation: C118S | Summary: The C118S mutation alters the redox-dependent reactions at this site, specifically blocking Ras activation, indicating a change in molecular function. Evidence Type: Oncogenic | Mutation: C118S | Summary: The C118S mutation in the Kras gene is implicated in tumorigenesis, contributing to tumor development or progression. Evidence Type: Functional | Mutation: G353>C | Summary: The G353>C transversion results in the C118S mutation, which affects the molecular function of Ras by blocking activation. Evidence Type: Oncogenic | Mutation: G353>C | Summary: The G353>C transversion is associated with the C118S mutation in Kras, which is known to contribute to tumorigenesis.

Gene→Variant (gene-first): 4843:C118 4843:C118S 4843:G353 transversion to C 4843:G353>C

Genes: 4843

Variants: C118 C118S G353 transversion to C G353>C

[Paper-level Aggregated] PMCID: PMC4234187

Evidence Type(s): Oncogenic, Functional, Predictive, Prognostic

Justification: Oncogenic: The introduction of the C118S mutation into the Kras gene was shown to affect tumorigenesis, specifically leading to fewer lung tumors in Kras+/C118S and KrasC118S/C118S mice when treated with the carcinogen urethane, indicating a role in oncogenic processes. Functional: The study demonstrated that the C118S mutation alters the function of the Kras protein, as it specifically blocks redox-dependent reactions that lead to Ras activation, impacting downstream signaling pathways such as the MAPK pathway. Predictive: The presence of the C118S mutation was associated with a reduced tumor burden and a shift towards smaller tumors in mice, suggesting that this mutation can predict a lower likelihood of tumor development in response to carcinogenic exposure. Prognostic: The findings indicate that mice with the C118S mutation have a different tumorigenic outcome compared to those with wild-type Kras, which could be used to prognosticate the progression and severity of lung tumors in a carcinogen-induced model.

Gene→Variant (gene-first): NOS2(4843):C118 NOS2(4843):C118S KRAS(3845):G13D NRAS(4893):Q61L NOS2(4843):G353 transversion to C NOS2(4843):G353>C NOS2(4843):cysteine 118 KRAS(3845):G12D NOS3(4846):S1177D KRAS(3845):Q61R/L NRAS(4893):Q61R

Genes: NOS2(4843) KRAS(3845) NRAS(4893) NOS3(4846)

Variants: C118 C118S G13D Q61L G353 transversion to C G353>C cysteine 118 G12D S1177D Q61R/L Q61R

[Paragraph-level] PMCID: PMC4234187 Section: ABSTRACT PassageIndex: 1

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses the introduction of a C118S mutation into the Kras allele and its effect on tumorigenesis, indicating that this somatic variant contributes to tumor development or progression. Functional: The passage describes how the thiol residue of cysteine 118 is involved in redox-dependent reactions that lead to Ras activation, suggesting that the C118S mutation alters molecular function related to protein activity.

Gene→Variant (gene-first): 4843:C118 4843:C118S 4843:cysteine 118

Genes: 4843

Variants: C118 C118S cysteine 118

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 16

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses the behavior of Kras mutations, specifically KrasC118S and KrasG13D, in the context of transformation and signaling, indicating their role in tumor development and progression. Functional: The analysis of P-Erk1/2 levels upon EGF treatment suggests that the KrasC118S variant alters molecular function related to signaling pathways, as evidenced by the immunoblotting results.

Gene→Variant (gene-first): 4843:C118 4843:C118S 3845:G13D 4893:Q61L

Genes: 4843 3845 4893

Variants: C118 C118S G13D Q61L

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 15

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses the identification of oncogenic mutations, specifically Q61R/L, in the context of tumor development in Kras+/C118S mice, indicating that these variants contribute to tumor progression. Functional: The mention of the C118S variant in the context of its allelic origin and mutation status suggests an alteration in molecular function related to the Kras gene, which is relevant to its role in oncogenesis.

Gene→Variant (gene-first): 4843:C118S 4893:Q61R 3845:Q61R/L

Genes: 4843 4893 3845

Variants: C118S Q61R Q61R/L

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 13

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses the KrasG12D allele as promoting lung tumorigenesis, indicating its role in tumor development. Functional: The passage describes the C118S mutation's effect on the tumorigenic activity of the oncogenic Kras allele and its interaction with the non-oncogenic allele, suggesting a change in molecular function related to tumor suppression.

Gene→Variant (gene-first): 4843:C118S 3845:G12D

Genes: 4843 3845

Variants: C118S G12D

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 12

Evidence Type(s): Oncogenic

Justification: Oncogenic: The passage indicates that the variants G12D and C118S are involved in similar tumorigenesis, suggesting that they contribute to tumor development or progression.

Gene→Variant (gene-first): 4843:C118S 3845:G12D

Genes: 4843 3845

Variants: C118S G12D

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 11

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses the impact of the KrasC118S variant on tumor progression and its association with different tumor types, indicating that this somatic variant contributes to tumor development or progression. Functional: The analysis shows that the KrasC118S variant is associated with reduced P-Akt signaling, suggesting that it alters molecular function related to signaling pathways involved in tumor biology.

Gene→Variant (gene-first): 4843:C118S

Genes: 4843

Variants: C118S

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 10

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses how the KrasC118S variant contributes to tumor development by resulting in fewer tumors and smaller average tumor sizes in mice, indicating its role in tumor progression. Functional: The presence of the KrasC118S allele is shown to alter the tumor characteristics, specifically leading to a shift towards smaller tumors, which suggests an alteration in molecular or biochemical function related to tumor development.

Gene→Variant (gene-first): 4843:C118S

Genes: 4843

Variants: C118S

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 9

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses the KrasC118S mutation in the context of its role in carcinogenesis and tumor development, particularly in relation to urethane-induced lung tumors characterized by oncogenic Q61R/L mutations in Kras. Functional: The passage implies that the KrasC118S mutation alters the molecular behavior of Kras in the context of tumorigenesis, as it is assessed for its impact on carcinogenesis and tumor development.

Gene→Variant (gene-first): 4843:C118S 3845:Q61R/L

Genes: 4843 3845

Variants: C118S Q61R/L

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 7

Evidence Type(s): Oncogenic, Prognostic

Justification: Oncogenic: The passage discusses the KrasC118S variant in the context of its role in mouse models, indicating that it does not lead to significant developmental or physiological defects, which suggests its involvement in tumor development or progression. Prognostic: The passage mentions the median lifespan of KrasC118S/C118S mice compared to Kras+/+ mice, indicating a potential correlation with disease outcome, although the difference was not statistically significant.

Gene→Variant (gene-first): 4843:C118S

Genes: 4843

Variants: C118S

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 6

Evidence Type(s): None

Justification: Not enough information in this passage.

Gene→Variant (gene-first): 4843:C118S

Genes: 4843

Variants: C118S

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 5

Evidence Type(s): Functional, Oncogenic

Justification: Functional: The passage discusses how the C118S mutation affects the ability of eNOS to stimulate the MAPK pathway and provides evidence of altered molecular function through immunoblot analysis of protein levels and activity. Oncogenic: The passage indicates that the C118S mutation is important for carcinogen-induced lung tumorigenesis, suggesting that it contributes to tumor development or progression.

Gene→Variant (gene-first): 4843:C118S 4843:G353>C 4846:S1177D

Genes: 4843 4846

Variants: C118S G353>C S1177D

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 3

Evidence Type(s): Functional, Oncogenic

Justification: Functional: The passage discusses how the C118S mutation specifically blocks redox-dependent reactions that lead to Ras activation, indicating an alteration in molecular function. Oncogenic: The context of the study involves investigating the effect of the C118S mutation on Ras function during tumorigenesis, suggesting that this somatic variant contributes to tumor development or progression.

Gene→Variant (gene-first): 4843:C118 4843:C118S 4843:G353 transversion to C 4843:G353>C

Genes: 4843

Variants: C118 C118S G353 transversion to C G353>C

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 16

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses the behavior of Kras mutations, specifically KrasC118S and KrasG13D, in the context of transformation and signaling, indicating their role in tumor development and progression. Functional: The analysis of P-Erk1/2 levels upon EGF treatment suggests that the KrasC118S variant alters molecular function related to signaling pathways, as evidenced by the immunoblotting results.

Gene→Variant (gene-first): 4843:C118 4843:C118S 3845:G13D 4893:Q61L

Genes: 4843 3845 4893

Variants: C118 C118S G13D Q61L

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 15

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses the identification of oncogenic mutations, specifically Q61R/L, in the context of tumor development in Kras+/C118S mice, indicating that these variants contribute to tumor progression. Functional: The mention of the C118S variant in the context of its allelic origin and mutation status suggests an alteration in molecular function related to the Kras gene, which is relevant to its role in oncogenesis.

Gene→Variant (gene-first): 4843:C118S 4893:Q61R 3845:Q61R/L

Genes: 4843 4893 3845

Variants: C118S Q61R Q61R/L

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 13

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses the KrasG12D allele as promoting lung tumorigenesis, indicating its role in tumor development. Functional: The passage describes the C118S mutation's effect on the tumorigenic activity of the oncogenic Kras allele and its interaction with the non-oncogenic allele, suggesting a change in molecular function related to tumor suppression.

Gene→Variant (gene-first): 4843:C118S 3845:G12D

Genes: 4843 3845

Variants: C118S G12D

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 12

Evidence Type(s): Oncogenic

Justification: Oncogenic: The passage indicates that the variants G12D and C118S are involved in similar tumorigenesis, suggesting that they contribute to tumor development or progression.

Gene→Variant (gene-first): 4843:C118S 3845:G12D

Genes: 4843 3845

Variants: C118S G12D

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 11

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses the impact of the KrasC118S variant on tumor progression and its association with different tumor types, indicating that this somatic variant contributes to tumor development or progression. Functional: The analysis shows that the KrasC118S variant is associated with reduced P-Akt signaling, suggesting that it alters molecular function related to signaling pathways involved in tumor biology.

Gene→Variant (gene-first): 4843:C118S

Genes: 4843

Variants: C118S

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 10

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses how the KrasC118S variant contributes to tumor development by resulting in fewer tumors and smaller average tumor sizes in mice, indicating its role in tumor progression. Functional: The presence of the KrasC118S allele is shown to alter the tumor characteristics, specifically leading to a shift towards smaller tumors, which suggests an alteration in molecular or biochemical function related to tumor development.

Gene→Variant (gene-first): 4843:C118S

Genes: 4843

Variants: C118S

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 9

Evidence Type(s): Oncogenic, Functional

Justification: Oncogenic: The passage discusses the KrasC118S mutation in the context of its role in carcinogenesis and tumor development, particularly in relation to urethane-induced lung tumors characterized by oncogenic Q61R/L mutations in Kras. Functional: The passage implies that the KrasC118S mutation alters the molecular behavior of Kras in the context of tumorigenesis, as it is assessed for its impact on carcinogenesis and tumor development.

Gene→Variant (gene-first): 4843:C118S 3845:Q61R/L

Genes: 4843 3845

Variants: C118S Q61R/L

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 7

Evidence Type(s): Oncogenic, Prognostic

Justification: Oncogenic: The passage discusses the KrasC118S variant in the context of its role in mouse models, indicating that it does not lead to significant developmental or physiological defects, which suggests its involvement in tumor development or progression. Prognostic: The passage mentions the median lifespan of KrasC118S/C118S mice compared to Kras+/+ mice, indicating a potential correlation with disease outcome, although the difference was not statistically significant.

Gene→Variant (gene-first): 4843:C118S

Genes: 4843

Variants: C118S

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 6

Evidence Type(s): None

Justification: Not enough information in this passage.

Gene→Variant (gene-first): 4843:C118S

Genes: 4843

Variants: C118S

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 5

Evidence Type(s): Functional, Oncogenic

Justification: Functional: The passage discusses how the C118S mutation affects the ability of eNOS to stimulate the MAPK pathway and provides evidence of altered molecular function through immunoblot analysis of protein levels and activity. Oncogenic: The passage indicates that the C118S mutation is important for carcinogen-induced lung tumorigenesis, suggesting that it contributes to tumor development or progression.

Gene→Variant (gene-first): 4843:C118S 4843:G353>C 4846:S1177D

Genes: 4843 4846

Variants: C118S G353>C S1177D

[Paragraph-level] PMCID: PMC4234187 Section: RESULTS PassageIndex: 3

Evidence Type(s): Functional, Oncogenic

Justification: Functional: The passage discusses how the C118S mutation specifically blocks redox-dependent reactions that lead to Ras activation, indicating an alteration in molecular function. Oncogenic: The context of the study involves investigating the effect of the C118S mutation on Ras function during tumorigenesis, suggesting that this somatic variant contributes to tumor development or progression.

Gene→Variant (gene-first): 4843:C118 4843:C118S 4843:G353 transversion to C 4843:G353>C

Genes: 4843

Variants: C118 C118S G353 transversion to C G353>C